News Image

Climb Bio Appoints Edgar D. Charles, M.D., MSc as Chief Medical Officer

Provided By GlobeNewswire

Last update: Jun 18, 2025

Dr. Charles, Accomplished Immunology-Focused Drug Developer, Brings More Than 20 years of Biopharma Leadership, Clinical Development, and Operations Expertise

Company Also Hires Cindy J. Driscoll, MBA, Financial Executive with Over Two Decades of Experience Guiding Biotechnology Companies, as Senior Vice President, Finance

Read more at globenewswire.com

CLIMB BIO INC

NASDAQ:CLYM (11/25/2025, 12:01:08 PM)

1.79

+0.03 (+1.7%)



Find more stocks in the Stock Screener

Follow ChartMill for more